Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 14 Jul 23 EFFECT Notice of effectiveness
- 13 Jul 23 424B3 Prospectus supplement
- 11 Jul 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
22 Jun 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 10 May 23 S-4 Registration of securities issued in business combination transactions
CRVO similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Amendment No. 1 to the Registration Statement (No. 333-271823) on Form S-4 of Diffusion Pharmaceuticals Inc. of our report dated May 10, 2023, relating to the financial statements of EIP Pharma, Inc., appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference of our firm under the heading “Experts” in such Registration Statement.
/s/ RSM US LLP
Boston, Massachusetts
June 22, 2023